Study of immune markers in B-cell blood cancers
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at certain proteins on B-cell blood cancer cells to understand them better. It may help doctors learn more about these cancers, but it is not a treatment trial.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are newly diagnosed with a B-cell blood cancer, such as B-cell acute lymphoblastic leukemia or chronic lymphocytic leukemia.
- You have not started chemotherapy yet.
- You do not have another type of cancer.
- You do not have an autoimmune disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain markers on your blood cancer cells to understand them better. By joining, you help doctors learn more about your disease, which may guide future care.
This study looks at blood tests to find markers of inflammation in people newly diagnosed with B-cell blood cancers (such as certain lymphomas, leukemias, and multiple myeloma). It may help doctors better understand these diseases and how they affect the body.
This study checks if two natural substances in your blood (called cytokines) are linked to how active your leukemia is. It aims to help doctors better understand and possibly predict the disease, which could guide future treatment.
This study looks at “biomarkers” (measurable signs in your tumor and possibly blood) to understand your lymphoma’s genetic make-up. The goal is to see which markers may help doctors decide on treatment and timing.
This study looks at whether a simple blood test can help predict outcomes in patients with newly diagnosed acute leukemia. The test measures the ratio of two proteins in your blood, which might give doctors clues about how the disease will progress.
This study is looking at blood and bone marrow samples from people with acute leukemia to understand how the immune system reacts to the disease and treatment. The goal is to find better ways to treat leukemia.
Hear when a new B Cell Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.